论文部分内容阅读
近年来我们在临床上应用阿魏酸钠辅助治疗2型糖尿病,并对尿微量白蛋白的影响进行了初步观察,现总结如下。资料与方法2型糖尿病住院患者80例,均符合WHO1999年颁布的诊断标准。将入选患者随机分成两组,阿魏酸钠组40例,其中男21例,女19例,年龄46~72岁,病程3~20年。常规组40例,其中
In recent years, we in the clinical application of sodium ferulate supplementation in the treatment of type 2 diabetes, and the impact of microalbuminuria were initially observed, are summarized as follows. Materials and Methods 80 patients with type 2 diabetes inpatients were in line with WHO1999 published diagnostic criteria. The selected patients were randomly divided into two groups, 40 cases of sodium ferulate group, including 21 males and 19 females, aged 46 to 72 years, duration of 3 to 20 years. Conventional group of 40 cases, of which